High-throughput detection of clinically targetable alterations using next-generation sequencing

Next-generation sequencing (NGS) has revolutionized the therapeutic care of patients by allowing high-throughput and parallel sequencing of large numbers of genes in a single run. However, most of available commercialized cancer panels target a large number of mutations that do not have direct thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Vendrell, Julie A., Grand, David, Rouquette, Isabelle, Costes, Valérie, Icher, Samira, Selves, Janick, Larrieux, Marion, Barbe, Aurore, Brousset, Pierre, Solassol, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522202/
https://www.ncbi.nlm.nih.gov/pubmed/28404952
http://dx.doi.org/10.18632/oncotarget.15875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522202/
https://www.ncbi.nlm.nih.gov/pubmed/28404952
http://dx.doi.org/10.18632/oncotarget.15875

Ejemplares similares